Literature DB >> 11682060

Over-expression of FoxM1 stimulates cyclin B1 expression.

T W Leung1, S S Lin, A C Tsang, C S Tong, J C Ching, W Y Leung, R Gimlich, G G Wong, K M Yao.   

Abstract

FoxM1 (previously named WIN, HFH-11 or Trident) is a Forkhead box (Fox) transcription factor widely expressed in proliferating cells. Various findings, including a recent analysis of FoxM1 knockout mice, suggest that FoxM1 is required for normal S-M coupling during cell cycle progression. To study the regulatory role of FoxM1 and its downstream regulatory targets, three stably transfected HeLa lines that display doxycycline (dox)-inducible FoxM1 expression were established. Over-expression of FoxM1 by dox induction facilitates growth recovery from serum starvation. Quantitation of cyclin B1 and D1 levels using flow cytometric, Western and Northern analyses reveals that elevated FoxM1 levels lead to stimulation of cyclin B1 but not cyclin D1 expression. Transient reporter assays in the dox-inducible lines and upon co-transfection with a constitutive FoxM1 expression plasmid suggest that FoxM1 can activate the cyclin B1 promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682060     DOI: 10.1016/s0014-5793(01)02915-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  77 in total

1.  FoxM1 mediates resistance to herceptin and paclitaxel.

Authors:  Janai R Carr; Hyun Jung Park; Zebin Wang; Megan M Kiefer; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.

Authors:  M L Golson; A Ackermann Misfeldt; U G Kopsombut; C P Petersen; M Gannon
Journal:  Open Endocrinol J       Date:  2010

3.  FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.

Authors:  Samuel K M Li; David K Smith; Wai Ying Leung; Alice M S Cheung; Eric W F Lam; Goberdhan P Dimri; Kwok-Ming Yao
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

4.  Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures.

Authors:  Dejan Juric; Sanja Sale; Robert A Hromas; Ron Yu; Yan Wang; George E Duran; Robert Tibshirani; Lawrence H Einhorn; Branimir I Sikic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

5.  The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.

Authors:  Nagaratna S Hegde; Deborah A Sanders; Raphaël Rodriguez; Shankar Balasubramanian
Journal:  Nat Chem       Date:  2011-08-21       Impact factor: 24.427

Review 6.  Forkhead box M1 transcription factor: a novel target for cancer therapy.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2009-12-22       Impact factor: 12.111

7.  FoxM1 involvement in astrocyte proliferation after spinal cord injury in rats.

Authors:  Shuangwei Zhang; Honglin Teng; Qiulei Ding; Jinpeng Fan; Wanying Shi; Yan Zhou; Chunwu Zhang
Journal:  J Mol Neurosci       Date:  2013-02-06       Impact factor: 3.444

8.  MEK inhibition increases lapatinib sensitivity via modulation of FOXM1.

Authors:  S S Gayle; R C Castellino; M C Buss; R Nahta
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Authors:  J Millour; D Constantinidou; A V Stavropoulou; M S C Wilson; S S Myatt; J M-M Kwok; K Sivanandan; R C Coombes; R H Medema; J Hartman; A E Lykkesfeldt; E W-F Lam
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

10.  Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.

Authors:  Hongjie Zhang; Jia Zhang; Christine F Pope; Laura A Crawford; Rupangi C Vasavada; Shubhada M Jagasia; Maureen Gannon
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.